Nutcracker Therapeutics
PrivateLast Round
Series C
Mar 14, 2022
Total Funding Raised
$241M
Company Overview
Nutcracker Therapeutics is a biotechnology company that develops mRNA-based therapeutic drug products through its innovative platform that integrates proprietary hardware, software, and advancements in mRNA biochemistry and nanoparticle delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Smart Manufacturing, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutcracker Therapeutics Comparables
Compare Nutcracker Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| eTheRNA | 81% | |
| Univercells | 81% | |
| Dillico | 71% | |
Nutcracker Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 14, 2022 | ||||
| Series B | Sep 23, 2020 | ||||
| Series A | Mar 21, 2019 | ||||
| Seed | May 17, 2018 |
Nutcracker Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series C, Series A |
| ARCH Venture Partners | Series A, Series B, Series C |
| ARCH Venture Partners | Series B, Series C |
| Bluebird Ventures | Series B, Series C, Series A |
| Sutter Hill Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 26, 2025
Cynthia Collins appointed Executive Chair and Interim CEO.
- Sep 23, 2020
$60M round led by ARCH Venture Partners.
Nutcracker Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nutcracker Therapeutics's valuation, stock price, and market status.